CFO Peter Trpkovski sold 16,739 shares of CENX at $50.51 for $845,486.89, reducing holdings by 20.7%
Trpkovski, the CFO, executed a substantial reduction in his CENX stake, selling 16,739 shares (20.7% of his pre-transaction holdings) at $50.51 on 2026-03-25. The current price of $49.65 is 14.5% below the 52-week high of $58.07, and the stock has declined 6.4% over the past 30 days despite a 23.6% gain over 90 days, suggesting volatility in the name. The company's fundamentals show strong revenue growth of 13.8% year-over-year with $632.2M in latest quarterly revenue, yet the elevated P/E of 118.21 reflects stretched valuation relative to current $14.9M quarterly net income. The reduction by a C-suite executive merits attention in the context of current valuation multiples and near-term price weakness, though the company's revenue trajectory remains positive.